The Asia Pacific Ashwagandha Extract Market would witness market growth of 11.1% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 25,702.40 thousand units, showcasing a growth of 11.2% (2019-2022).
In the market, capsules and tablets have become popular delivery forms for Ashwagandha supplementation due to their convenience and precise dosage control. Encapsulating Ashwagandha extract into pills offers consumers a straightforward and portable way to incorporate this herbal supplement into their daily routines. Capsules and tablets provide standardized doses of Ashwagandha, ensuring consistency in potency and simplifying the process of supplementation for individuals seeking stress relief, immune support, and overall well-being. Therefore, the China market make use of 6,396.03 thousand units of capsules and tablets in 2022.
The China market dominated the Asia Pacific Ashwagandha Extract Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $280.2 Million by 2030. The Japan market is registering a CAGR of 10.4% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 11.7% during (2023 - 2030).
The extract is increasingly available in traditional supplement stores, mainstream retail outlets, pharmacies, and e-commerce platforms. This wider availability contributes to the accessibility of ashwagandha products to a broader consumer base. Ongoing research into the therapeutic properties of ashwagandha, including its effects on stress, anxiety, cognitive function, and immune health, is driving interest in the market. Clinical trials validating ashwagandha’s efficacy and safety will likely further fuel its growth.
As research on ashwagandha’s effects on exercise performance continues, its use in sports nutrition products is expected to grow. Manufacturers are exploring innovative formulations and delivery methods to make extract more convenient and appealing to consumers. This includes the development of ashwagandha-infused beverages, functional foods, and personalized supplement blends. There is a trend toward premium and high-quality extracts standardized for bioactive compounds such as with anolides.
According to Invest India, Indian e-commerce is estimated to develop at a 27% compound annual growth rate, reaching $163 billion by 2026. Indian consumers are becoming more health-conscious and are actively seeking natural remedies and supplements to support their overall well-being. E-commerce platforms offer convenience and accessibility, allowing consumers in India to browse, purchase, and receive extract products from the comfort of their homes. Positive customer reviews and testimonials on e-commerce platforms are social proof of extract’s efficacy and quality, influencing purchase decisions and building consumer trust in India. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.
Based on the Distribution Channel, the market is segmented into Business to Consumer, and Business to Business. Based on Form, the market is segmented into Capsules/Tablets, Powder, and Others. Based on Application, the market is segmented into Dietary Supplements, Sports Nutrition, Food & Beverages, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
In the market, capsules and tablets have become popular delivery forms for Ashwagandha supplementation due to their convenience and precise dosage control. Encapsulating Ashwagandha extract into pills offers consumers a straightforward and portable way to incorporate this herbal supplement into their daily routines. Capsules and tablets provide standardized doses of Ashwagandha, ensuring consistency in potency and simplifying the process of supplementation for individuals seeking stress relief, immune support, and overall well-being. Therefore, the China market make use of 6,396.03 thousand units of capsules and tablets in 2022.
The China market dominated the Asia Pacific Ashwagandha Extract Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $280.2 Million by 2030. The Japan market is registering a CAGR of 10.4% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 11.7% during (2023 - 2030).
The extract is increasingly available in traditional supplement stores, mainstream retail outlets, pharmacies, and e-commerce platforms. This wider availability contributes to the accessibility of ashwagandha products to a broader consumer base. Ongoing research into the therapeutic properties of ashwagandha, including its effects on stress, anxiety, cognitive function, and immune health, is driving interest in the market. Clinical trials validating ashwagandha’s efficacy and safety will likely further fuel its growth.
As research on ashwagandha’s effects on exercise performance continues, its use in sports nutrition products is expected to grow. Manufacturers are exploring innovative formulations and delivery methods to make extract more convenient and appealing to consumers. This includes the development of ashwagandha-infused beverages, functional foods, and personalized supplement blends. There is a trend toward premium and high-quality extracts standardized for bioactive compounds such as with anolides.
According to Invest India, Indian e-commerce is estimated to develop at a 27% compound annual growth rate, reaching $163 billion by 2026. Indian consumers are becoming more health-conscious and are actively seeking natural remedies and supplements to support their overall well-being. E-commerce platforms offer convenience and accessibility, allowing consumers in India to browse, purchase, and receive extract products from the comfort of their homes. Positive customer reviews and testimonials on e-commerce platforms are social proof of extract’s efficacy and quality, influencing purchase decisions and building consumer trust in India. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.
Based on the Distribution Channel, the market is segmented into Business to Consumer, and Business to Business. Based on Form, the market is segmented into Capsules/Tablets, Powder, and Others. Based on Application, the market is segmented into Dietary Supplements, Sports Nutrition, Food & Beverages, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Kerry Group PLC
- Dabur India Ltd.
- Emami Limited
- The Procter and Gamble Company
- Patanjali Ayurved Limited
- Himalaya Wellness Company (Himalaya Global Holdings Ltd.)
- Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
- Unilever PLC
- Taos Herb Company
- Kairali Ayurvedic Group
Market Report Segmentation
By Distribution Channel (Volume, Thousand Units, USD Billion, 2019-2030)- Business to Consumer
- Business to Business
- Capsules/Tablets
- Powder
- Others
- Dietary Supplements
- Sports Nutrition
- Food & Beverages
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Ashwagandha Extract Market by Distribution Channel
Chapter 5. Asia Pacific Ashwagandha Extract Market by Form
Chapter 6. Asia Pacific Ashwagandha Extract Market by Application
Chapter 7. Asia Pacific Ashwagandha Extract Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Kerry Group PLC
- Dabur India Ltd.
- Emami Limited
- The Procter and Gamble Company
- Patanjali Ayurved Limited
- Himalaya Wellness Company (Himalaya Global Holdings Ltd.)
- Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
- Unilever PLC
- Taos Herb Company
- Kairali Ayurvedic Group
Methodology
LOADING...
